Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine and folic acid in children with ADHD receiving Ritalin
IRCT201203167462N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyproheptadine, folic acid and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
cyproheptadinefolic acidmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201203167462N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201203167462N5.